Knilonat Capsules (Nilotinib) 150mg and 200mg are targeted cancer medicines used under specialist medical supervision for certain patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). Nilotinib belongs to the tyrosine kinase inhibitor (TKI) class and works by inhibiting the abnormal BCR-ABL protein involved in the growth of leukemia cells. Knilonat 150mg & 200mg Uses Knilonat contains Nilotinib, which may be prescribed for eligible patients with Ph+ CML, depending on their disease phase, previous treatment and medical condition. It may be used for: Newly diagnosed Ph+ CML in the chronic phase CML in patients who are resistant or intolerant to certain previous treatments Selected CML patients requiring targeted BCR-ABL inhibition Treatment should always be prescribed and monitored by a qualified hematologist or oncologist. Benefits of Nilotinib Nilotinib offers targeted treatment by blocking BCR-ABL tyrosine kinase. Potential benefits include: Helps control abnormal leukemia-cell growth Provides targeted treatment for Ph+ CML Available in 150mg and 200mg capsule strengths Oral treatment option May help patients achieve important hematologic, cytogenetic and molecular responses when appropriately prescribed The choice of strength and treatment schedule depends on the individual patient's condition and previous therapy. How to Take Knilonat Capsules Nilotinib should be taken exactly as prescribed by your doctor. It is generally taken on an empty stomach. Patients are commonly advised to avoid food for at least 2 hours before taking nilotinib and for at least 1 hour afterward. Do not change the dose, stop treatment or take additional capsules without medical advice. Avoid grapefruit and grapefruit juice because they can affect nilotinib levels. Tell your healthcare professional about all medicines, vitamins and supplements you take. Knilonat Side Effects Like other cancer medicines, Nilotinib can cause side effects. Possible side effects include: Headache Nausea Fatigue Rash or itching Muscle or joint pain Abdominal discomfort Low blood-cell counts Changes in liver or pancreatic blood tests Changes in bilirubin levels Nilotinib can also cause potentially serious effects, including QT-interval prolongation and abnormal heart rhythms, cardiovascular events, pancreatitis, liver toxicity and electrolyte abnormalities. Seek urgent medical attention for symptoms such as fainting, severe chest pain, severe breathing difficulty or symptoms suggesting a serious allergic or cardiac reaction. Knilonat Nilotinib in USA, UK, UAE & South Africa Patients searching for Knilonat 150mg and 200mg or Nilotinib for CML in the USA, UK, UAE and South Africa should obtain the medicine through appropriate prescription and regulatory channels. Availability, prescribing requirements, approved indications and import regulations can differ between countries. Patients should consult a qualified healthcare professional before using Nilotinib. Frequently Asked Questions What is Knilonat 150mg? Knilonat 150mg contains Nilotinib, a tyrosine kinase inhibitor used for appropriate patients with Philadelphia chromosome-positive CML. What is Knilonat 200mg used for? Knilonat 200mg contains Nilotinib and may be prescribed for eligible CML patients. The appropriate strength is determined by the treating specialist. Is Nilotinib chemotherapy? Nilotinib is a targeted tyrosine kinase inhibitor, rather than conventional cytotoxic chemotherapy. It specifically targets BCR-ABL tyrosine kinase. Can Nilotinib be taken with food? Nilotinib is generally taken on an empty stomach. Follow the exact instructions provided by your doctor and the applicable product information. What are the common side effects of Nilotinib? Common effects may include headache, nausea, fatigue, rash, itching, muscle pain, abdominal discomfort and changes in blood counts. Can I stop taking Knilonat when I feel better? No. Do not stop Nilotinib without speaking with your treating specialist. Treatment decisions should be based on your medical response and monitoring results. Does Nilotinib require a prescription? Yes. Nilotinib is a prescription oncology medicine that should be used under appropriate medical supervision. Why Choose a Reliable Pharmaceutical Supplier? When sourcing oncology medicines, buyers should verify: Product authenticity Manufacturer and batch information Expiry date Proper packaging and storage Required prescription or import documentation Compliance with destination-country regulations